Dr. Streeter joined Astrocyte Pharmaceutical’s Board of Directors in November of 2020. He is the Managing Director of the UF Innovate venture fund and a Venture Partner at DeepWork Capital. Before joining UF Innovate, he was the CEO and executive director of the Florida Technology Seed Capital Fund, a seed-stage venture fund investing in companies commercializing technologies developed at Florida universities, colleges, or research institutes. Dr. Streeter has extensive experience leading companies developing diagnostics/therapeutics for both traumatic brain injury and ischemic stroke. He was the CEO of Banyan Biomarkers for eight years, commercializing the first-ever blood test for traumatic brain injury that received FDA clearance in early 2018. Dr. Streeter also founded and served as CEO for PhotoThera, Inc., where over thirteen years he raised more than $120M in private capital and designed and managed five U.S. and international clinical trials for the treatment of stroke. He also co-founded American Veterinary Laser, which was acquired in a private transaction. He is the inventor of more than 20 patented technologies and the author on multiple scientific publications.
Dr. Streeter earned his B.S. degree in biology from the University of Nevada Reno and his M.D. from the University of Nevada School of Medicine. He served as an officer in the U.S. Navy, completing a general surgery internship at Naval Regional Medical Center in Portsmouth, Virginia, and then primary flight school at the Naval Air Station in Pensacola. During his military service, he was the first naval flight surgeon selected as a Top Gun staff instructor, served on several overseas deployments, and was awarded the Navy Achievement Medal and the Navy Commendation Medal. Dr. Streeter served on the Department of Defense Grey Team where he went to Afghanistan to evaluate Traumatic Brain Injury treatment and care of Warfighters in theater during Operation Enduring Freedom.